Novo Nordisk – Think You Know the Truth About Compounded “Semaglutide”?

At Novo Nordisk, patient safety is a top priority.  As the sole manufacturer of FDA-approved medicines containing semaglutides, Novo Nordisk is deeply concerned by companies promoting and selling non-FDA-approved knock-off drugs that claim to contain the same “semaglutide.”  As a result of the concerning dynamics in the marketplace, Novo Nordisk is committed to raising awareness of the dangers of compounded or knock-off “semaglutide”.  Here are three important facts to know if you or someone you care for is considering an unapproved, compounded product.

Latest Posts
Partner News
Segal Benz: Boosting Engagement in Employee Well-Being Programs
Employee well-being—mental, physical, and financial—is a top priority for many organizations. When employees feel supported, ...
Read More
Partner News
Aon: 2025 Employee Sentiment Study
This study is based on findings from Aon’s Employee Sentiment survey and insights from Aon’s ...
Read More
Partner News
Wellthy: Where Care Meets Work – New Data on Caregiving and Backup Care Benefits
Caregiving has long been a reality for employees, and its impact on the workforce is ...
Read More
Follow SVEF
Scroll to Top

Join the Mailing List

Contact the Team

You must be logged in to fill out this form.